TOME-Logo-RGB.png
Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform
December 12, 2023 07:57 ET | Tome Biosciences
Tome Biosciences launches with over $200 million in funding to advance programmable genomic integration (PGI).
DBMR Logo.png
Genomic Medicine Market is Probable to Influence the Value of USD 75.67 Billion by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Analysis
May 16, 2023 04:30 ET | Data Bridge Market Research
BOSTON, May 16, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research's latest report, "Genomic Medicine Market" provides a thorough analysis of growth strategies, drivers, opportunities, key...
Featured Image for Experimental Biology and Medicine
Genomic transposable elements modify the progression of Parkinson's disease
November 08, 2022 10:00 ET | Experimental Biology and Medicine
WASHINGTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 18, September, 2022) improves our understanding of genomic...
OpGen.jpg
U.S. Patent Allowed Covering Acuitas Lighthouse® Software
October 23, 2019 07:30 ET | OpGen, Inc.
GAITHERSBURG, Md., Oct. 23, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that the United States Patent and Trademark Office (the “USPTO”) has allowed a key OpGen patent...
OpGen.jpg
OpGen Provides update on Curetis Group’s R&D Collaboration
September 18, 2019 07:30 ET | OpGen, Inc.
Curetis R&D collaboration to develop NGS-based predictive antibiotic resistance testing powered by ARESdbCollaborator to fund R&D and obtains option to license ARESdb and ARES Technology...
OpGen.jpg
OpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance Congress
September 08, 2016 07:30 ET | OpGen, Inc.
GAITHERSBURG, Md., Sept. 08, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it will participate in the World Anti-Microbial Resistance Congress being held September 8-9 in...
Elsevier Publishes Medical Epigenetics, New Landmark Volume in Translational Epigenetics Series
June 14, 2016 04:00 ET | Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - June 14, 2016) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of Medical...